FDA official logo
GSRS logoPFDA official logo

ESEPAPOGENE ZALARNAREPVEC

UNII:VA2XPJ9DMK
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:ESEPAPOGENE ZALARNAREPVEC
GSRS Full Record:

  • 2632271-13-5
  • ESEPAPOGENE ZALERNAREPVEC [USAN]
  • Esepapogene zalarnarepvec
  • HB-201 component r3LCMV-E7E6
  • HB-201 segment L
  • RNA (lymphocytic choriomeningitis virus vector HB-201 segment L), supramolecular complex with RNA (lymphocytic choriomeningitis virus vector HB-201 segment S-2 human papillomavirus 16 [24-glycine,26-glycine,91-glycine] gene E7 protein fusion protein with [69-glycine,112-glycine] gene E6 protein transgene plus membrane glycoprotein GPC-specifying), supramolecular complex with RNA (lymphocytic choriomeningitis virus vector HB-201 segment S-1 human papillomavirus 16 [24-glycine,26-glycine,91-glycine] gene E7 protein fusion protein with [69-glycine,112-glycine] gene E6 protein transgene plus nucleocapsid protein-specifying)
  • TT1-E7E6 component r3LCMV-E7E6
  • recombinant replication-competent attenuated arenavirus (lymphocytic choriomeningitis virus [LCMV] strain clone 13) expressing the glycoprotein of LCMV strain WE instead of its endogenous glycoprotein (alternatively designated as rCl13/WE-GP) vector with two copies of the small (S) genome segment (S RNA segment), with one encoding the viral membrane glycoprotein (GP) and one encoding the viral nucleocapsid protein (NP), and both encoding a synthetic human papillomavirus type 16 E7E6 fusion protein (with mutations of C24G, E26G and C91G in E7 and C69G and C112G in E6), and with a wild type large (L) genome segment (L RNA segment). Expression of the E7E6 fusion protein is under control of the viral expression mechanism.



UNII - VA2XPJ9DMK | UNII Search Service